Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy.
暂无分享,去创建一个
Katsushi Inoue | Masahiro Ishizuka | Motowo Nakajima | Shun-ichiro Ogura | S. Ogura | M. Nakajima | N. Komatsu | Kiwamu Takahashi | M. Ishizuka | F. Abe | Y. Sano | Katsushi Inoue | T. Kohda | Tohru Tanaka | Naoki Komatsu | Fuminori Abe | Yuki Sano | Kiwamu Takahashi | Takeo Kohda | Tohru Tanaka
[1] Jarod C Finlay,et al. The role of photodynamic therapy (PDT) physics. , 2008, Medical physics.
[2] H. Biesalski,et al. Inhibition of heme oxygenase-1 increases responsiveness of melanoma cells to ALA-based photodynamic therapy. , 2007, International journal of oncology.
[3] B. Ames,et al. Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging? , 2009, The American journal of clinical nutrition.
[4] N. Radin,et al. The rôle of acetic acid in the biosynthesis of heme. , 1950, The Journal of biological chemistry.
[5] S. Kaneko. [Intraoperative photodynamic diagnosis of human glioma using ALA induced protoporphyrin IX]. , 2001, No shinkei geka. Neurological surgery.
[6] S. Sassa. [Gene regulation by free heme]. , 2007, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.
[7] Stefan Seeger,et al. Metabolic Characterization of Tumor Cell–specific Protoporphyrin IX Accumulation After Exposure to 5-Aminolevulinic Acid in Human Colonic Cells¶ , 2002 .
[8] S. Remy,et al. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. , 2005, Blood.
[9] J C Kennedy,et al. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.
[10] H. Matsui,et al. The role of nitric oxide in delta-aminolevulinic acid (ALA)-induced photosensitivity of cancerous cells. , 2007, Biochemical and biophysical research communications.
[11] Christoph Abels,et al. Targeting of the vascular system of solid tumours by photodynamic therapy (PDT) , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[12] M. Korbelik. Photodynamic therapy-generated cancer vaccines. , 2010, Methods in molecular biology.
[13] D. Kang,et al. Effects of delta-aminolevulinic acid and vitamin C supplementation on feed intake, backfat, and iron status in sows. , 2009, Journal of animal science.
[14] M. Korbelik,et al. Photodynamic therapy-generated vaccines: relevance of tumour cell death expression , 2007, British Journal of Cancer.
[15] M. Kolácková,et al. Scavenger receptor CD163 and its biological functions. , 2009, Acta medica.
[16] K. Furuyama,et al. Role of the heme regulatory motif in the heme-mediated inhibition of mitochondrial import of 5-aminolevulinate synthase. , 2004, Journal of biochemistry.
[17] S. Gollnick,et al. Enhancement of anti-tumor immunity by photodynamic therapy , 2010, Immunologic research.
[18] P. Agostinis,et al. Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity , 2010, Apoptosis.
[19] H. Winn,et al. Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. , 1998, Neurosurgery.
[20] T. Tagawa,et al. Synergistic interaction of 5-aminolevulinic acid-based photodynamic therapy with simultaneous hyperthermia in an osteosarcoma tumor model. , 2006, International journal of oncology.
[21] Sang Kook Lee,et al. Suppression of lipopolysaccharide-stimulated inducible nitric oxide synthase (iNOS) expression by a novel humulene derivative in macrophage cells. , 2009, International immunopharmacology.
[22] N. Agarwal,et al. Erythropoietic agents and the elderly. , 2008, Seminars in hematology.
[23] R. Hardison,et al. Hemoglobins from bacteria to man: evolution of different patterns of gene expression. , 1998, The Journal of experimental biology.
[24] B. Prakken,et al. Hsp70 and cardiac surgery: molecular chaperone and inflammatory regulator with compartmentalized effects , 2009, Cell Stress and Chaperones.
[25] S. Calderwood,et al. T Cell Activation by Heat Shock Protein 70 Vaccine Requires TLR Signaling and Scavenger Receptor Expressed by Endothelial Cells-11 , 2009, The Journal of Immunology.
[26] A. Neuberger,et al. The metabolism of delta -aminolaevulic acid. 2. Normal pathways, studied with the aid of 14C. , 1956, The Biochemical journal.
[27] A. Straughn,et al. Clinical pharmacokinetics of 5-aminolevulinic acid in healthy volunteers and patients at high risk for recurrent bladder cancer. , 2002, The Journal of pharmacology and experimental therapeutics.
[28] N. Radin,et al. The rôle of glycine in the biosynthesis of heme. , 1950, The Journal of biological chemistry.
[29] H. Kato,et al. Systemic Antitumor Effect of Intratumoral Injection of Dendritic Cells in Combination with Local Photodynamic Therapy , 2006, Clinical Cancer Research.
[30] Y Kitagawa,et al. Influence of administration methods on the accumulation of ALA-induced Pp-IX in mouse tongue tumors. , 2006, Oral diseases.
[31] N. Gamaleia,et al. Effect of photodynamic therapy on tumor angiogenesis and metastasis in mice bearing Lewis lung carcinoma. , 2005, Experimental oncology.
[32] P. Vaupel,et al. Intensified oxidative and nitrosative stress following combined ALA‐based photodynamic therapy and local hyperthermia in rat tumors , 2003, International journal of cancer.
[33] A. Neuberger,et al. The metabolism of delta -aminolaevulic acid. 1. Normal pathways, studied with the aid of 15N. , 1956, The Biochemical journal.
[34] Zheng Huang,et al. Combination of Photodynamic Therapy and Immunomodulation: Current Status and Future Trends , 2008 .
[35] A. Neuberger,et al. The metabolism of δ-aminolaevulic acid. 1. Normal pathways, studied with the aid of 15N , 1956 .
[36] K. T. Moesta,et al. Silencing of human ferrochelatase causes abundant protoporphyrin‐IX accumulation in colon cancer , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[37] A. Oseroff,et al. Enhanced Systemic Immune Reactivity to a Basal Cell Carcinoma Associated Antigen Following Photodynamic Therapy , 2009, Clinical Cancer Research.
[38] H. Atamna,et al. Heme, iron, and the mitochondrial decay of ageing , 2004, Ageing Research Reviews.
[39] A. Oseroff,et al. Aminolevulinic acid photodynamic therapy for skin cancers. , 2007, Dermatologic clinics.
[40] Gorobets Ob,et al. Effect of photodynamic therapy on tumor angiogenesis and metastasis in mice bearing Lewis lung carcinoma. , 2005 .
[41] F. Zanella,et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.
[42] P. Price,et al. Is the hypoxia-inducible factor pathway important in gastric cancer? , 2005, European journal of cancer.
[43] M. Ishizuka,et al. Hair growth stimulatory effect by a combination of 5‐aminolevulinic acid and iron ion , 2008, International journal of dermatology.
[44] T. Billiar,et al. Linking oxidative stress to inflammation: Toll-like receptors. , 2010, Free radical biology & medicine.
[45] M. Miyake,et al. siRNA‐mediated Knockdown of the Heme Synthesis and Degradation Pathways: Modulation of Treatment Effect of 5‐Aminolevulinic Acid‐based Photodynamic Therapy in Urothelial Cancer Cell Lines , 2009, Photochemistry and photobiology.
[46] S. Moestrup,et al. Hemoglobin and heme scavenger receptors. , 2010, Antioxidants & redox signaling.
[47] Hirofumi Fujita,et al. Mechanism of cell death by 5‐aminolevulinic acid‐based photodynamic action and its enhancement by ferrochelatase inhibitors in human histiocytic lymphoma cell line U937 , 2009, Cell biochemistry and function.
[48] A Gorchein,et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study. , 1995, Gut.
[49] Jarod C Finlay,et al. The role of photodynamic therapy (PDT) physics. , 2008, Medical physics.
[50] W. Jun. Biosynthesis, Biotechnological Production and Applications of 5-Aminolevulinic acid , 2004 .
[51] H. Nauwynck,et al. Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy. , 2010, Molecular immunology.
[52] G. Martin. Topical photodynamic therapy is immunosuppressive in humans , 2011 .
[53] P. Vaupel,et al. Enhanced effects of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumours , 2003, British Journal of Cancer.
[54] Z. Malik,et al. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. , 1987, British Journal of Cancer.
[55] M. Mota,et al. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria , 2007, Nature Medicine.
[56] H. Matsui,et al. Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin. , 2005, Biochemical pharmacology.
[57] H Stepp,et al. Fluorescence-guided resections of malignant gliomas--an overview. , 2003, Acta neurochirurgica. Supplement.
[58] W. Fan,et al. Heme oxygenase-1 system and gastrointestinal tumors. , 2010, World journal of gastroenterology.
[59] Young-Guen Kwon,et al. Interactive relations between nitric oxide (NO) and carbon monoxide (CO): heme oxygenase-1/CO pathway is a key modulator in NO-mediated antiapoptosis and anti-inflammation. , 2008, Methods in enzymology.
[60] L. Skivka,et al. 5-aminolevulinic acid mediated photodynamic therapy of Lewis lung carcinoma: a role of tumor infiltration with different cells of immune system. , 2004, Experimental oncology.
[61] B. Krammer,et al. Photodynamic therapy with aminolevulinic acid or its methyl ester: Which one is superior? , 2009 .
[62] J. D. Engel,et al. Expression of delta-aminolevulinate synthase in avian cells: separate genes encode erythroid-specific and nonspecific isozymes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[63] H. Yasuda,et al. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer. , 2008, Nitric oxide : biology and chemistry.
[64] B. Ames,et al. Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[65] K. Soo,et al. The effect of photodynamic therapy on tumor angiogenesis , 2009, Cellular and Molecular Life Sciences.
[66] J. Byun,et al. Expression of IL-10, TGF-beta(1) and TNF-alpha in Cultured Keratinocytes (HaCaT Cells) after IPL Treatment or ALA-IPL Photodynamic Treatment. , 2009, Annals of dermatology.
[67] H. Fukuda,et al. Tumour-localizing properties of porphyrins. In vivo studies using free and liposome encapsulated aminolevulinic acid. , 1992, Comparative biochemistry and physiology. B, Comparative biochemistry.
[68] N. Abraham,et al. Pharmacological and Clinical Aspects of Heme Oxygenase , 2008, Pharmacological Reviews.
[69] Taoyong Chen,et al. Stress for maintaining memory: HSP70 as a mobile messenger for innate and adaptive immunity , 2010, European journal of immunology.
[70] T. Ishikawa,et al. Nrf2-dependent induction of human ABC transporter ABCG2 and heme oxygenase-1 in HepG2 cells by photoactivation of porphyrins: biochemical implications for cancer cell response to photodynamic therapy. , 2008, Journal of experimental therapeutics & oncology.
[71] Tatiana P. Dutra,et al. Heme Induces Neutrophil Migration and Reactive Oxygen Species Generation through Signaling Pathways Characteristic of Chemotactic Receptors* , 2007, Journal of Biological Chemistry.
[72] Zhe Zhang,et al. Effect of 5-ALA-PDT on VEGF and PCNA expression in human NPC-bearing nude mice. , 2009, Oncology reports.
[73] H. Zankl,et al. Protoporphyrin IX-accumulation in human tumor cells following topical ALA- and h-ALA-application in vivo. , 2003, Cancer letters.
[74] S. Yazdanfar,et al. Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypes. , 2010, Journal of biomedical optics.
[75] P. Dobbin,et al. Sustained and efficient porphyrin generation in vivo using dendrimer conjugates of 5-ALA for photodynamic therapy. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[76] R. Chou,et al. ALA‐PDT results in phenotypic changes and decreased cellular invasion in surviving cancer cells , 2009, Lasers in surgery and medicine.
[77] K. Soo,et al. Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma. , 2005, International journal of molecular medicine.
[78] A. Oseroff,et al. PDT as a cytotoxic agent and biological response modifier: Implications for cancer prevention and treatment in immunosuppressed and immunocompetent patients. , 2006, The Journal of investigative dermatology.
[79] N. Breusing,et al. Light-induced cytotoxicity after aminolevulinic acid treatment is mediated by heme and not by iron. , 2010, Journal of photochemistry and photobiology. B, Biology.
[80] C. Gomer,et al. Photodynamic therapy: Combined modality approaches targeting the tumor microenvironment , 2006, Lasers in surgery and medicine.
[81] M. Goldman,et al. Endotoxin‐Induced Myeloid‐Derived Suppressor Cells Inhibit Alloimmune Responses via Heme Oxygenase‐1 , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[82] A. Girotti,et al. Cytoprotective induction of nitric oxide synthase in a cellular model of 5-aminolevulinic acid-based photodynamic therapy. , 2010, Free radical biology & medicine.
[83] M. Timko,et al. Regulation by heme of mitochondrial protein transport through a conserved amino acid motif. , 1993, Science.
[84] T. Horio,et al. Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid , 2007, The Journal of dermatology.
[85] T. Tagawa,et al. Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia. , 2005, International Journal of Oncology.
[86] W. Zhong,et al. The role of heme oxygenase-1 in T cell-mediated immunity: the all encompassing enzyme. , 2008, Current pharmaceutical design.
[87] S. Kaneko. A Current Overview : Photodynamic Diagnosis and Photodynamic Therapy using 5-Aminolevulinic Acid in Neurosurgery , 2008 .
[88] R. Figueiredo,et al. Characterization of Heme as Activator of Toll-like Receptor 4* , 2007, Journal of Biological Chemistry.
[89] G. Schuler,et al. Pivotal Advance: Heme oxygenase 1 expression by human CD4+ T cells is not sufficient for their development of immunoregulatory capacity , 2010, Journal of leukocyte biology.
[90] A. Gorchein. Determination of delta-aminolaevulinic acid in biological fluids by gas-liquid chromatography with electron-capture detection. , 1984, Biochemical Journal.
[91] H Stepp,et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. , 1998, Neurosurgery.
[92] A. Józkowicz,et al. Heme oxygenase-1 in tumors: is it a false friend? , 2007, Antioxidants & redox signaling.
[93] Kiriko Kaneko,et al. Heme as a magnificent molecule with multiple missions: heme determines its own fate and governs cellular homeostasis. , 2007, The Tohoku journal of experimental medicine.
[94] Zheng Huang,et al. Photodynamic Therapy for Treatment of Solid Tumors — Potential and Technical Challenges , 2008, Technology in cancer research & treatment.
[95] P. Fontoura,et al. Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. , 2007, The Journal of clinical investigation.
[96] J. Paterniti,et al. delta-Aminolevulinic acid synthetase: regulation of activity in various tissues of the aging rat. , 1978, Archives of biochemistry and biophysics.